GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (OTCPK:DNPUF) » Definitions » 12-1 Month Momentum %

Sumitomo Pharma Co (Sumitomo Pharma Co) 12-1 Month Momentum % : -61.35% (As of May. 01, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sumitomo Pharma Co 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-01), Sumitomo Pharma Co's 12-1 Month Momentum % is -61.35%.

The industry rank for Sumitomo Pharma Co's 12-1 Month Momentum % or its related term are showing as below:

DNPUF's 12-1 Month Momentum % is ranked worse than
88.5% of 1113 companies
in the Drug Manufacturers industry
Industry Median: -7.46 vs DNPUF: -61.35

Competitive Comparison of Sumitomo Pharma Co's 12-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Sumitomo Pharma Co's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sumitomo Pharma Co's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sumitomo Pharma Co's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Sumitomo Pharma Co's 12-1 Month Momentum % falls into.



Sumitomo Pharma Co  (OTCPK:DNPUF) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sumitomo Pharma Co  (OTCPK:DNPUF) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Sumitomo Pharma Co 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Sumitomo Pharma Co's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sumitomo Pharma Co (Sumitomo Pharma Co) Business Description

Traded in Other Exchanges
Address
6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.